PMID: 16625817
Obesity drugs in clinical development.
Halford Jason C G
Current opinion in investigational drugs (London, England : 2000) · 2006
Vol. 7, Issue 4, pp. 312-8
This entry links to third-party literature. For research use only.
AmyloidAnimalsAnti-Obesity AgentsAppetite DepressantsEnergy MetabolismGlucagon-Like Peptide 1HumansIslet Amyloid PolypeptideObesityPeptide Fragments